 |
eculizumab |
|---|---|
| Trade Name | Soliris |
| Orphan Indication | Shiga-Toxin producing escherichia coli hemolytic uremic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2011-10-18 00:00:00 |
| Sponsor | Alexion Pharmaceuticals, Inc.;352 Knotter Drive;Cheshire, Connecticut, 06410 |
